Back
ESC2025 Premium Access

NATURE-LEGACY: Long term legacy benefit of Lowering LDL and SBP

Session: Late-Breaking Clinical Science: lipids and cardiovascular risk
Topic: Drug therapy
Speaker: Professor B. Ference (Cambridge, GB)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Professor Brian A Ference

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)
33 presentations
9 followers

5 more presentations in this session

LipoaScreen – cascade screening for lipoprotein(a)

Speaker: Associate Professor J. Brinck (Stockholm, SE)

Access
Slides
Like
Thumbnail

Triglyceride lowering after MI

Speaker: Ms J. Schubert (Uppsala, SE)

Access
Slides
Like
Thumbnail

Obicetrapib and cardiovascular events

Speaker: Professor S. Nicholls (Melbourne, AU)

Access
Slides
Like
Thumbnail

GAELp(a): National Registry on Lp(a) and Cardiovascular Risk in Argentina

Speaker: Doctor N. Renna (Mendoza, AR)

Access
Slides
Like
Thumbnail

Carotid plaques stabilization and regression with evolocumab

Speaker: Doctor T. Aranzulla (Turin, IT)

Access
Slides
Like
Thumbnail

Access the full session

Late-Breaking Clinical Science: lipids and cardiovascular risk

Speakers: Professor B. Ference, Associate Professor J. Brinck, Ms J. Schubert, Professor S. Nicholls, Doctor N. Renna...
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources